首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1671851

非侵入性產前檢測 (NIPT) 市場按產品/服務、應用、技術、時間段、最終用戶和地區分類

Non-invasive Prenatal Testing (NIPT) Market, By Product & Service, By Application, By Technology, By Period, By End User, By Geography

出版日期: 2025年02月26日 | 出版商:

Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球非侵入性產前檢測 (NIPT) 市場規模估計為 50.8 億美元，預計到 2032 年將達到 101.5 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 10.4%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	50.8億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	10.40％	2032 年價值預測	101.5億美元

數字。 2025 年非侵入性產前檢測 (NIPT)市場佔有率（%）（按地區分類）

全球非侵入性產前檢測（NIPT）市場用於篩檢母親血液中的胎兒DNA，以確定胎兒是否有遺傳異常的高風險，而無需在懷孕期間或對胎兒進行任何侵入性程序。這些測試分析了母親血液中循環的胎盤遊離DNA（cfDNA）。它可以檢測您患上唐氏症、13 三體症、18 三體症、性染色體非整倍體和其他異常等遺傳疾病的風險。隨著基因組技術的進步，NIPT 已成為產前篩檢的先鋒技術之一，並因其提供準確的結果並避免與羊膜穿刺術等侵入性檢查相關的流產風險而受到全球孕婦的廣泛歡迎。

市場動態：

全球非侵入性產前檢測 (NIPT) 市場受到多種因素的推動，例如母親年齡增加、唐氏症嬰兒出生率上升、對 NIPT 認知的不斷提高以及診斷工具的技術進步。然而，低收入國家獲得診斷服務的有限性和對墮胎的道德擔憂阻礙了市場的成長。重大商機包括新興國家尚未開發的市場，以及正在進行的擴大NIPT應用的研究和開發，NIPT可檢測基因突變和染色體微缺失/重複。

本研究的主要特點

本報告對全球無創產前檢測 (NIPT) 市場進行了詳細分析，並提供了預測期 (2025-2032) 的市場規模和年複合成長率（CAGR%），假設 2024 年為基準年。

它揭示了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。

全球無創的產前檢測 (NIPT) 市場的主要企業是根據公司亮點、產品系列、關鍵亮點、績效和策略等參數列出。

研究涉及的主要企業包括 Illumina, Inc.、Natera, Inc.、Roche Diagnostics、Ariosa Diagnostics、Verinata Health, Inc.、Yourgene Health、Centogene NV、Eurofins Scientific、F. Hoffmann-La Roche Ltd.、LabCorp、Quest Diagnostics、BGIomeics, Technologies Toffmann-La Roche Ltd。

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球無創產前檢測 (NIPT) 市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員可以透過分析全球無創產前檢測（NIPT）市場所使用的各種策略矩陣來簡化決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	US$ 5.08 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.40%	2032 Value Projection:	US$ 10.15 Bn

Global Non-invasive Prenatal Testing (NIPT) Market is used to screen fetal DNA in the mother's bloodstream to check if the fetus is at a high risk of genetic abnormalities without being invasive to the pregnancy or the fetus. These tests analyze cell-free DNA (cfDNA) from the placenta that circulates in the mother's bloodstream. They can check the risk of genetic conditions like Down's syndrome, Trisomy 13, Trisomy 18, sex chromosome aneuploidies, and other abnormalities. With advancements in genomic technologies, NIPT has become one of the pioneering techniques used for prenatal screening and is gaining immense popularity among expectant mothers worldwide as it provides accurate results and avoids risks of miscarriage associated with invasive tests like amniocentesis.

Market Dynamics:

The global Non-invasive Prenatal Testing (NIPT) market is driven by factors such as increasing maternal age, rising incidence of babies born with Down's syndrome, growing awareness about NIPT, and technological advancements in diagnostic tools. However, limited access to diagnostic services in low-income countries and ethical issues related to abortion restrain market growth. Significant opportunities include untapped markets in developing countries and ongoing R&D to expand applications of NIPT to detect genetic mutations and chromosomal microdeletion or duplications.

Key Features of the Study:

This report provides in-depth analysis of the global Non-invasive Prenatal Testing (NIPT) market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global Non-invasive Prenatal Testing (NIPT) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Illumina, Inc., Natera, Inc., Roche Diagnostics, Ariosa Diagnostics, Verinata Health, Inc., Yourgene Health, Centogene N.V., Eurofins Scientific, F. Hoffmann-La Roche Ltd., LabCorp, Quest Diagnostics, BGI Genomics, MedGenome Labs, Genetic Technologies Limited, and Myriad Genetics, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global Non-invasive Prenatal Testing (NIPT) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Non-invasive Prenatal Testing (NIPT) market

Market Segmentation

By Product & Service Insights (Revenue, USD Bn, 2020 - 2032)
- Product
- Consumables
- Assay Kits and Reagents
- Instruments
- Services
By Application Insights (Revenue, USD Bn, 2020 - 2032)
- Trisomy Detection
- Microdeletion Detection
- Sex Chromosome Aneuploidy Detection
By Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Array Technology
- Rolling Circular Amplification
By Period Insights (Revenue, USD Bn, 2020 - 2032)
- 0-12 Weeks
- 13-24 Weeks
- 25-36 Weeks
By End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Diagnostic Laboratories
- Home Care Settings
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Illumina, Inc.
- Natera, Inc.
- Roche Diagnostics
- Ariosa Diagnostics
- Verinata Health, Inc.
- Yourgene Health
- Centogene N.V.
- Eurofins Scientific
- Hoffmann-La Roche Ltd.
- LabCorp
- Quest Diagnostics
- BGI Genomics
- MedGenome Labs
- Genetic Technologies Limited
- Myriad Genetics, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Non-invasive Prenatal Testing (NIPT) Market, By Product & Service
- Global Non-invasive Prenatal Testing (NIPT) Market, By Application
- Global Non-invasive Prenatal Testing (NIPT) Market, By Technology
- Global Non-invasive Prenatal Testing (NIPT) Market, By Period
- Global Non-invasive Prenatal Testing (NIPT) Market, By End User
- Global Non-invasive Prenatal Testing (NIPT) Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Non-invasive Prenatal Testing (NIPT) Market, By Product & Service, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Product
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Consumables
Assay Kits and Reagents
Instruments
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Non-invasive Prenatal Testing (NIPT) Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Trisomy Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Microdeletion Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sex Chromosome Aneuploidy Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Non-invasive Prenatal Testing (NIPT) Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Array Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rolling Circular Amplification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Non-invasive Prenatal Testing (NIPT) Market, By Period, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
0-12 Weeks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
13-24 Weeks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
25-36 Weeks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Non-invasive Prenatal Testing (NIPT) Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Non-invasive Prenatal Testing (NIPT) Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Period, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Period, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Period , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Period , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Period , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Period, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Natera, Inc.
Roche Diagnostics
Ariosa Diagnostics
Verinata Health, Inc.
Yourgene Health
Centogene N.V.
Eurofins Scientific
Hoffmann-La Roche Ltd.
LabCorp
Quest Diagnostics
BGI Genomics
MedGenome Labs
Genetic Technologies Limited
Myriad Genetics, Inc.